china
-
Bayer HealthCare, Tsinghua University in partnership
Both partners signed a new strategic agreement to collaborate in the area of biomedical sciences over the next three years.
china | 07 May 2012
-
China remains one of the fastest growing pharmaceutical markets in the world
China and Japan will be the largest and second largest pharmaceutical markets in the Asia Pacific region in 2016.
china | 27 April 2012
-
GE Healthcare opens training center in China
GE Healthcare announced the official opening of its expanded Fast Trak Training Center in Shanghai, China.
china | 20 April 2012
-
Sigma-Aldrich opens packaging, quality control facilities In China
Sigma-Aldrich announced the opening of its facility in Wuxi, China, that will provide localized packaging, analytical services and quality control for high-quality products to support research and industrial customers in the region.
china | 16 April 2012
-
Pharmaceutical companies from Japan, India and China are amongst Asia Pacific’s most innovative
Pharmaceutical companies from Japan, India and China were among Asia Pacific’s leading innovators last year according to one of two reports released by Thomson Reuters, which provide new insights into global patent and trademark trends throughout 2011.
china | 28 March 2012
-
Pharmaceutical circulation enterprises see relatively low profit margin in China
In China, pharmaceutical circulation enterprises see relatively low profit margin due to many circulation links. By sales value, some 20 percent of drugs are sold to consumers through pharmaceutical retail firms, and the rest (80 percent) are sold out through hospitals (including hospitals, community and township hospitals), according to Research and Markets.
china | 19 March 2012
-
Life Technologies partners with DaAn Gene
Life Technologies announced that it has signed an agreement with DaAn Gene, a Chinese company in molecular in-vitro diagnostics (IVD), to form Life Technologies DaAn Diagnostics, a joint venture diagnostics business in China. The move is expected to contribute to the early diagnosis of oncology, infectious diseases and genetic diseases. Financial terms of the deal were not disclosed.
china | 05 March 2012
-
Victoza now available to people with type 2 diabetes in China
Approved by the Chinese State Food and Drug Administration (SFDA) on 15 March 2011.
china | 10 October 2011
-
AstraZeneca increases investment in China with new $200 million manufacturing facility
New manufacturing facility will enable AstraZeneca to meet the growing demand for its products in China.
china | 10 October 2011
-
Nycomed and Almirall announce a licensing agreement for ebastine in China and other key Southeast Asia markets
• With this agreement, Almirall extends the global reach of the product, present now in more than 30 countries worldwide.
china | 29 September 2011
